SPED & Neurospirochetosis: Endothelial Invasion and a Century of Neglected Evidence

This is a direct follow-up to: Part One.

The story we uncovered in Part One didn't start in the 1970s with the "discovery" of Lyme. It stretches back over a century. And the century-old evidence is not suppressed fringe material. It is mainstream medicine's own record. Autopsy series from the pre-antibiotic era found spirochetes in the brains of general paresis patients in up to 100 percent of examined cases, localized to gray matter and, critically for this article, inside endothelial and microglial cells (Ghanem 2010, PMID 20626434). The problem was never that the evidence did not exist. The problem is that its lessons were not carried forward.

Now the Spike Protein is using the same route: the endothelium as the doorway to multi-system illness, while patients with persistent symptoms meet the same dismissal Lyme patients know well.

This isn't a new pattern. It's a 100-year-old pattern repeating in real-time.

TRUTH BOMB: The pattern is not a century of denial. It is a century of lag. Spirochetal invasion of the brain, endothelial cells included, was demonstrated in autopsy tissue in 1913 (Noguchi, PMID 19867640). Acceptance took decades longer than the evidence warranted. Every round of this argument has eventually been settled by tissue, not opinion. Long COVID is working through that same pipeline right now.

The Century-Old Endothelial Invasion Blueprint

Both the Lyme pathogen and the Spike Protein center their pathology on the same doorway: the endothelium.

We can learn a great deal about the Spike Protein by studying Lyme disease. The similarities are not coincidental, they are mechanistic: convergent exploitation of the vascular endothelium. But be precise about what converges. The target is shared; the tools are not. Borrelia burgdorferi is a living, motile, replicating bacterium with adhesins, chemotaxis, and antigenic variation. The Spike is a protein with no motility and no replication of its own, and its documented vascular effects are host-mediated responses. Same highway, different vehicles.

Shared Pathogenic Strategies

Both Borrelia burgdorferi (Lyme disease) and the SARS-CoV-2 Spike Protein exploit the endothelium as a gateway to systemic dissemination. The process involves:

• Endothelial Transmigration: For Borrelia this is direct and proven: it crosses endothelial monolayers both between cells (paracellular, at tight junctions) and through them (transcellular), and crossing requires viable, motile spirochetes (Comstock and Thomas 1991, PMID 1890951). The Spike does not transmigrate on its own; whole virus infects endothelium via ACE2, and isolated Spike inflames and activates the endothelium without any viral replication (Montezano 2023, PMID 37640791)
• Fibronectin and Integrin Engagement: Borrelia's adhesin BBK32 binds fibronectin and glycosaminoglycans and behaves as a catch bond that strengthens under shear, with plasma fibronectin stabilizing vascular attachment (Niddam 2017, PMID 28396443; Hyde 2017, PMID 28270812). The Spike's S1 binds beta-1 integrins, the fibronectin receptors, independent of ACE2 (Park 2021, PMID 33918599). Whether the Spike exploits a fibronectin bridge under flow has not been tested
• Immune Evasion: Both utilize mechanisms such as antigenic variation, biofilm formation (Borrelia), and immune modulation (Spike Protein) to persist in host tissues

The target tissue is the same. Once engaged, both drive pathology along the same vascular highways, but by different means: one an invading organism, the other a ligand triggering host responses.

The Dissemination Pathway: A Proven Playbook

Before we continue, let's be clear: when I reference "Spike Protein," I'm talking about the pathogenic entity itself whether it arrives via SARS-CoV-2 infection or other delivery methods. The source matters less than the mechanism.

Here's what happens once either pathogen enters your system:

1. The pathogen may be eliminated by host defenses (if you're lucky)
2. The pathogen may remain localized, causing initial symptoms (skin rash for Lyme, respiratory distress for Spike)
3. Within days to weeks, the pathogen disseminates through blood and lymphatics

After entering circulation, both show distinct tropism for:

• Skin (Lyme rashes) vs. Vascular endothelium (Spike Protein microclots)
• Heart (Lyme carditis) vs. Heart (Spike Protein myocarditis)
• Central Nervous System (Lyme neuroborreliosis) vs. Brain (Spike Protein neuroinflammation)
• Joints (Lyme arthritis) vs. Joints (Spike Protein autoimmune arthritis)

Clinical Parallels and Disease Progression

The clinical progression rhymes:

Lyme Disease Stages:

1. Early localized (skin)
2. Early disseminated (multiple systems)
3. Chronic disseminated (persistent multi-organ)

Spike Protein Disease Stages:

1. Acute infection (respiratory)
2. SPED - Multi-system inflammation
3. Long COVID/Chronic complications

Both conditions progress from localized to disseminated and chronic stages, with overlapping clinical features: neurological, cardiac, and rheumatological involvement.

One caveat: the Lyme staging is textbook. The "SPED stages" column is an analogy for orientation, not a validated staging framework.

SCIENCE SPOTLIGHT: For Borrelia, the fibronectin mechanism is settled science: plasma fibronectin stabilizes the spirochete's grip on the endothelium under shear through a catch-bond mechanism (Niddam et al., PNAS 2017, PMID 28396443). For the Spike, the same idea is an open question. S1 binds beta-1 integrins, the fibronectin receptors, independent of ACE2, but only in static assays so far (Park et al., Viruses 2021, PMID 33918599). Whether the Spike exploits a fibronectin bridge under flow has not been tested. A flow-chamber assay with labeled plasma fibronectin and S1 would answer it.

Cardiac Manifestations: Mirror Images

Lyme Carditis:

• Occurs in ~8% of patients, median 21 days post-infection
• AV block, myopericarditis, conduction disturbances
• A direct result of spirochetal invasion of cardiac tissue
• Often dismissed as "rare" with a "good prognosis"

Source: Yeung and Baranchuk, J Am Coll Cardiol 2019, PMID 30765038

Spike Protein Carditis:

• Chest pain, ECG abnormalities, arrhythmias
• Postural orthostatic tachycardia syndrome (POTS)
• Chronic perimyocarditis with ventricular failure
• Arterial wall inflammation, microthrombosis
• A direct result of Spike Protein endothelial injury and inflammation
• Often dismissed as "anxiety" or "post-viral syndrome"

Source: Montezano AC, et al. SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication. Sci Rep 2023, PMID 37640791

** HISTORICAL RED FLAG:** The minimization of cardiac and neurological involvement is a hallmark of the spirochetal denial playbook. What was called "hysteria" or "hypochondria" in syphilis and Lyme patients is now called "Long COVID anxiety" or "post-vaccine stress." The script is unchanged.

Persistent Infection and Immune Evasion

Borrelia's Advanced Evasion Arsenal

Research has highlighted Borrelia's advanced evasion tactics, which we now see reflected in Spike Protein pathology:

Borrelia's Bag of Tricks:

• Pleomorphism: Shape-shifting into cystic and granular forms (documented in autopsy studies)
• Biofilm Formation: Protects against immune clearance and antibiotics
• CNS Persistence: Documented in autopsy studies
• Polymicrobial Synergy: Requires complex, multi-target therapy

Source: Čorak N, et al. Int J Mol Sci 2023, PMID 36982667

Spike Protein Parallels

Spike Protein's Evasion Tactics (a modern echo):

• Tissue Persistence: Detected months post-infection/vaccination
• Mitochondrial and Epigenetic Disruption: Alters host cell function
• Autoimmunity: Molecular mimicry triggers chronic inflammation
• Resistance to Simple Mono-therapies: Requires comprehensive approach

The medical establishment's response to both? Deny the complexity, attack those who treat it, and gaslight the patients.

The 100-Year Denial Playbook: From Syphilis to SPED

They've Been Lying About Spirochetes Since Before We Were Born

Forensic pathology work provides the smoking gun: spirochetes have been observed in the brains of neurodegenerative patients for over a hundred years. The evidence was published in the standard literature of its day. What it met was not erasure but inertia, and the reflexive "contamination" objection for anyone who pushed.

This research, building on a century of ignored findings, demonstrates that the denial is not a bug in the system; it is a feature.

The corruption is foundational. Willy Burgdorfer, Ph.D., the namesake of the bacterium, admitted the quiet part out loud:

"Serology or serology plus has to be started from scratch with people that don't know beforehand the results of their research, just because they have to get the money."

Source: Burgdorfer interview

The system is not designed to find the truth about persistent infection. It is built to produce commercially viable, simple narratives.

The Transmission Cover-Up: Beyond the Official Narrative

Investigations into the microbiology of Borrelia challenged the simplistic "tick bite" narrative. The evidence for broader transmission has been documented for decades but sits outside the standard narrative:

The Under-Discussed Evidence:

• Congenital Transmission: Suggested by molecular and microscopic diagnostics in a 2026 case report (Bemis, Microorganisms 2026, PMID 41753693), and documented for relapsing-fever Borrelia as far back as 1969 (Fuchs, JAMA 1969, PMID 5818572). The counter-side deserves its say: a 2024 mouse study found no congenital Lyme transmission (Velásquez et al., Microbes Infect 2024, PMID 38380602). The question is open, not closed
• Multiple Arthropod Vectors: Beyond just Ixodes ticks
• Presence in Human Fluids: Suggesting potential for other routes of transmission

Medical Persecution and Censorship

The censorship playbook used against COVID dissenting physicians was perfected on Lyme doctors for decades. Researchers publishing findings that challenged the dominant paradigm faced immense resistance. Clinicians who treated chronic Lyme based on patient symptoms and complex testing risked their medical licenses.

The Pattern of Suppression:

1. Deny Complexity: ("It's all in your head")
2. Attack the Messengers: (License threats, character assassination)
3. Gaslight the Victims: ("Medically unexplained symptoms")
4. Protect the Narrative: At all costs

The medical establishment's insistence on a narrow transmission window for Lyme created a perfect model for the later denial of aerosol and asymptomatic spread of SARS-CoV-2. The playbook was already written.

The Co-infection Reality: Warnings Ignored

Decades of clinical and patient-advocacy work consistently emphasized that Lyme disease is rarely a monoinfection. The complex interplay with pathogens like B. miyamotoi, and how other infections like Bartonella and Babesia create a much more severe, complex illness.

The critical lesson: treating one pathogen in a polymicrobial illness is a recipe for failure. This is precisely what we see with Long COVID and Spike Protein injuries, where reactivation of latent viruses (EBV, HSV) and bacterial imbalances are the norm, not the exception.

The Hidden Reservoir

Long-standing documentation highlighted the sheer tenacity and unpredictability of Borrelia, including its ability to hide in biofilms, its pleomorphic forms, and its presence in unexpected tissues.

This understanding of pathogen persistence, specifically an enemy that does not play by the textbook rules, is the legacy of that body of work. It is the exact mindset required to understand why the Spike Protein does not simply "clear" from the body, but can persist and cause ongoing damage, much like the spirochetes that work documented.

The Convergence: A Century in the Making

The intersections between these two systematically denied conditions are not coincidental. They are the result of the same flawed model of medicine confronting a complex biological reality.

Lessons Unlearned: Historical Continuity

COVID/Spike Protein pathology is confirming what chronic-Lyme researchers argued for years: that persistent, stealth pathogens can cause a vast spectrum of chronic illness that rigid medical bureaucracies are incapable of diagnosing or treating.

The fraudulent handling has been identical across both diseases:

** THE BOTTOM LINE:** The model of infectious disease as an acute, easily-treated event is a dangerous fantasy. Their work stands as a warning: we must understand persistence, complexity, and immune evasion, or we will continue to fail millions.

Where the Analogy Breaks

The Way Forward: Medical Sovereignty

The path has already been carved out by the researchers and patients who came before. Healing requires operating outside the failed medical machine.

The solution pathway, learned from decades of Lyme advocacy:

1. Find independent clinicians who understand complex chronic illness
2. Educate yourself beyond mainstream medical narratives
3. Trust clinical evidence over restrictive, politicized guidelines
4. Build patient communities for knowledge sharing and support
5. Pursue multi-system, personalized approaches that address the root causes of persistence and inflammation

The pattern is clear: when the system is set up to fail you, you must build your own path to healing, just as the Lyme community had to.

International Lyme and Associated Diseases Society FLCCC Post-Vaccine Treatment Protocol

There Is Hope in the Fight Itself

While the systematic denial is staggering, there is profound hope in the continuity of this fight. This body of work provides not just a warning, but a roadmap. It proves that the truth exists, even when it is suppressed, and that dedicated individuals can uncover it.

The answers are being advanced by:

• Independent physicians using the principles of complex chronic illness management
• Patient advocates applying the hard-won lessons from the Lyme wars
• Courageous researchers who prioritize truth over funding
• Clinical innovators developing the sophisticated, multi-pronged protocols that these conditions demand

What you can do right now, informed by a century of this struggle:

1. Recognize the historical pattern - This is not your fault, and you are not crazy. You are facing a well-established systemic failure
2. Find your allies - Seek out doctors and communities who operate on the principles these researchers fought for
3. Educate yourself deeply - Understand the science of persistence, endothelial dysfunction, and immune evasion
4. Trust your body's signals - You are the ultimate authority on your lived experience
5. Become unmanageable - Do not accept dismissal. The legacy of this century-long fight is that patient perseverance is the most powerful force for change

The medical establishment has failed us on both fronts. But we don't need their permission to heal, and we can stand on the work of the researchers who came before us.

Key Research & Legacy

Key Literature:

• MS and Lyme research summary (PDF)
• Noguchi: A demonstration of Treponema pallidum in the brain in cases of general paralysis, J Exp Med 1913 (PMID 19867640) - the 1913 tissue proof
• Ghanem: Neurosyphilis, a historical perspective and review, CNS Neurosci Ther 2010 (PMID 20626434) - the paresis autopsy record
• Miklossy: Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria, J Neuroinflammation 2011 (PMID 21816039) - hypothesis-grade
• MacDonald: Plaques of Alzheimer's disease originate from cysts of Borrelia burgdorferi, Med Hypotheses 2006 (PMID 16675154) - hypothesis-grade; Med Hypotheses is a hypothesis-tier venue, treat accordingly

Modern Corroboration:

• Plasma fibronectin stabilizes Borrelia-endothelial interactions under vascular shear, PNAS 2017 (PMID 28396443) - Borrelia-specific
• Spike protein induces endothelial inflammation via ACE2, independent of viral replication, Sci Rep 2023 (PMID 37640791)
• Spike protein-induced microvascular damage, mouse and human pericytes, Signal Transduct Target Ther 2023 (PMID 37268620)
• Oxidative stress-induced endothelial dysfunction in COVID-19, eBioMedicine 2022 (PMID 35219085)
• Damage to endothelial barriers and its contribution to long COVID, Angiogenesis 2024 (PMID 37103631)
• Spike glycoprotein binds beta-1 integrins, Viruses 2021 (PMID 33918599)
• Borrelia dissemination and invasion review, Front Immunol 2017 (PMID 28270812)
• Borrelia invasion of cultured endothelial cells, Microb Pathog 1991 (PMID 1890951)
• Borrelia, host-derived proteases, and the blood-brain barrier, Infect Immun 2005 (PMID 15664945)
• Borrelia persists in the central nervous system in the nonhuman primate, Ann Neurol 1995 (PMID 7574465)
• Pleomorphic variants of Borrelia burgdorferi, Int J Mol Sci 2023 (PMID 36982667)

** THE FINAL, UNLEARNED LESSON:** They have been telling patients with persistent spirochetal illness that they are wrong for over 100 years. They are now telling Spike Protein injury patients the same thing. Researchers dedicated their lives to proving this a lie. Honor that work by refusing to believe it. The path to healing is difficult, but it is real, and it is paved with the truth they fought to uncover.

Share this analysis. The greatest weapon against a century of gaslighting is a century of evidence, finally connected.

This analysis builds on the important work of Walter M. Chesnut and his research into Spike Protein Endothelial Disease. Follow his essential work at WMCResearch.substack.com.

Educational content, not medical advice. Work with a clinician for diagnosis/treatment.